28-Mar-2024
No headlines found.
Globe Newswire (Thu, 29-Feb 4:05 PM ET)
Globe Newswire (Thu, 15-Feb 11:30 PM ET)
Globe Newswire (Mon, 12-Feb 7:30 AM ET)
Globe Newswire (Thu, 8-Feb 4:05 PM ET)
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.
Organogenesis Hldgs trades on the NASDAQ stock market under the symbol ORGO.
As of March 28, 2024, ORGO stock price climbed to $2.84 with 243,793 million shares trading.
ORGO has a beta of 1.57, meaning it tends to be more sensitive to market movements. ORGO has a correlation of 0.05 to the broad based SPY ETF.
ORGO has a market cap of $372.78 million. This is considered a Small Cap stock.
Last quarter Organogenesis Hldgs reported $100 million in Revenue and $.01 earnings per share. This fell short of revenue expectation by $-9 million and met earnings estimates .
In the last 3 years, ORGO stock traded as high as $24.34 and as low as $1.80.
The top ETF exchange traded funds that ORGO belongs to (by Net Assets): VTI, IWM, VXF, IWN, SCHA.
ORGO has outperformed the market in the last year with a return of +44.2%, while the SPY ETF gained +33.6%. However, in the most recent history, ORGO shares have underperformed the stock market with its stock returning -32.5% in the last 3 month period and -5.3% for the last 2 week period, while SPY has returned +10.1% and +1.7%, respectively.
ORGO support price is $2.64 and resistance is $2.88 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ORGO stock will trade within this expected range on the day.